维普期刊资源整合服务平台（V6.5）

59篇 您的检索式：作者名="TOSCHI L"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	EGFR,HER2,and phospho-Akt are not predictive factors for response to first-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC)显示文摘	Toschi L Metro G Magrini E	2006	J Clin Oncol2006，24，18：	1
2	Classification of Pecorino cheeses using electronic nose combined with artificial neural network and comparison with GC-MS analysis of volatile compounds显示文摘	Cevoli C Cerretani L Gori A Caboni MF Toschi TG Fabbri A		0，，：	1
3	Role of gemcit-abine in cancer therapy显示文摘	Toschi L Finocch iaro G Barto lini S	2005	Future Oncol2005，1，：	1
4	Single-agent and combination therapeutic strategies to inhibit hepatocyte growth factor/MET signaling in cancer显示文摘	Toschi L Janne PA		0，，19：	1
5	Epidermal growth factor receptor (EGFR) targeted therapies in non-small cell lung cancer (NSCLC) 显示文摘	Metro G Finocchiaro G Toschi L	2006	Rev Recent Clin Trials2006，1，1：	1
6	Single-agent and combination therapeutic strategies to inhibit hepatocyte growth factor/MET signaling in cancer显示文摘	Toschi L J(a)nne PA	2008	Clin Cancer Res2008，14，：	1
7	Shear-improved Smagorinsky model for large-eddy simulation of wall- bounded turbulent flows显示文摘	L6v6que E Toschi F Shao L	2007	Journal of Fluid Mechan-ics2007，570，：	1
8	Insulin-like growth factor re-ceptorl(IGFR-I)is significantly associated with longer survival in-non-small-cell lung cancer patients treated with gefitinib 显示文摘	Cappuzzo F Toschi L Tallini G	2006	AnnOncol2006，17，7：	1
9	Epidermal growth factor receptor (EGFR) targeted therapies in non-small cell lung cancer (NSCLC) 显示文摘	Metro G Finocchiaro G Toschi L	2006	Rev Recent Clin Trials2006，1，1：	1
10	Insulin- like growth factor receptor 1 ( IGFR- 1 ) is significantly associated with longer survival in non-small-cell lung cancer patients trea- ted with gefitinib显示文摘	CAPPUZZO F TOSCHI L TALLINI G	2006	Ann Oncol2006，17，7：	1
11	Insulin-like growth factor receptor 1 (IGFR-1) is significantly associated with longer survival in non-small-cell lung cancer patients treated with gefitinib显示文摘	Cappuzzo F Toschi L Tallini G	2006	Annals of Oncology2006，17，7：	1
12	Single-agent and combination therapeutic strategies to inhibit hepatocyte growth factor/MET signaling in cancer 显示文摘	Toschi L Janne PA	2008	Clin Cancer Res2008，14，19：	1
13	Insulin like growth fac- tor receptor 1 (IGFR-1) is significantly associated with longer survival in non-small-cell lung cancer patients treated with gefitinib显示文摘	Cappuzzo F Toschi L Tallini G	2006	AnnOneol2006，17，7：	1
14	Regulation of mTORC1 and mTORC2 complex assembly by phosphatidic acid: competition with rapamycin显示文摘	Toschi A Lee E Xu L	2009	Mol Cell Biol2009，29，6：	1
15	Clinical implications of MET gene copy number in lung cancer显示文摘	Toschi L Cappuzzo F	2010	Future Oncol2010，6，2：	1
16	Clinical implications of MET gene copy number in lung cancer显示文摘	Toschi L Cappuzzo F		0，，：	1
17	Impact of biomarkers on non-small cell lung cancer treatment显示文摘	Toschi L Cappuzzo F		0，，01：	1
18	Understanding the new genetics of responsiveness to epidermal growth factor receptor tyrosine kinase inhibitors显示文摘	Toschi L Cappuzzo F	2007	Oncologist2007，12，2：	1
19	Surrogate predictive biomarkers for response to anti-EGFR agents: State of the art and challenges 显示文摘	cappuzzo F Toschi L Finocchiaro G	2007	Int J Biol Markers2007，22，14：	1
20	Shear-improved Smagorinsky model for large-eddy simulation of wall-bounded turbulent flows显示文摘	Lévêque E Toschi F Shao L	2007	Journal of Fluid Mechanics2007，570，：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示